Importance of Newborn Bloodspots Survey

A new policy is proposed to destroy all newborn bloodspots (also known as heelprick tests, dried blood spots and Guthrie cards) at age 5 years. There has been no consultation. We understand that reasons are financial, relating to the cost of storage, rather than medical. Following an appeal by patients and doctors, Public Health England have now asked for evidence that the bloodspots are helpful to patients.

The bloodspot (Guthrie card) test is the only way of diagnosing congenital cytomegalovirus (CMV) in children and young people over 3 weeks of age.  Without the bloodspot, congenital CMV cannot be diagnosed for children over three weeks of age and young people as the cause of their symptoms.

This survey has been designed in collaboration with CMV Action (www.cmvaction.org.uk) and a Consultant Audiovestibular Physician. The information gathered will be anonymous and shared with Public Health England and other stakeholders involved in the consultation. If you have more than one child/young person who has had the bloodspot CMV test then please kindly complete one survey per child/young person. If you have any questions about the survey please contact CMV Action (www.cmvaction.org.uk). 
Please complete the survey by Monday 18th June. Thank you very much for taking the time to complete this survey.

Question Title

* 1. Are you a member of the NDCS, CMV Action or both?

Question Title

* 2. In which county/area of the UK/Ireland was your child/young person born?

Question Title

* 3. What symptoms/problems/signs prompted the investigation for congenital CMV for your child/young person?

Question Title

* 5. Which type of medical doctor arranged the CMV investigations? e.g. Paediatrician, Audiovestibular Physician, Paediatric Infectious Diseases doctor, ENT surgeon, GP, Other

Question Title

* 6. Was the newborn bloodspot tested for CMV?

Question Title

* 7. At what age (in years) was the newborn bloodspot tested for CMV?

Question Title

* 8. Was the result positive?

Question Title

* 9. If the test was positive, was it helpful to confirm congenital CMV as a cause of the symptoms?

Question Title

* 10. Did the diagnosis of congenital CMV result in further medical checks?

  Yes No Don't know Not applicable
Developmental checks
Eye checks
Balance function checks
Referral to paediatric infectious diseases

Question Title

* 11. Did the diagnosis of congenital CMV affect genetic testing or counselling?

Question Title

* 12. Did the diagnosis of congenital CMV affect audiological care? e.g. frequency of audiology appointments, use of hearing aid(s), referral for cochlear implant

Question Title

* 13. Did the diagnosis of congenital CMV affect therapies? e.g. referral for, or provision of physiotherapy, occupational therapy, speech and language therapy

Question Title

* 14. Was the diagnosis of congenital CMV helpful regarding educational provision? e.g. obtaining an Education Health Care Plan (EHCP)/statement of educational needs/individual education plan (IEP), informing the input from a teacher of the deaf, other support at school.

Question Title

* 15. Was the diagnosis of congenital CMV helpful in order to receive appropriate social support e.g. disability living allowance (DLA), personal independence payment (PIP),  or help for housing?

Question Title

* 16. If the bloodspot CMV test was negative, was it helpful to have had all the tests possible to check for congenital CMV?

Question Title

* 17. What would have been the effect if the bloodspot had not been available for testing?

Question Title

* 18. Please add any further comments or suggestions on the importance of storing the bloodspots beyond age 5 years. Thank you for your help with this survey.

T